New Study shows increased Risks of Birth Cancer among those who use Birth Control
The largest study to date exploring the correlation between CHC use and risk of breast cancer (BC) in women aged 15–49 years enrolled 1.8 million Danish women who were recently or currently using CHC. They were followed for up to an average of 11 years. The study concluded:
ALL FORMS OF BIRTH CONTROL LEAD TO A HIGHER RISE IN BREAST CANCER!
All forms of CHC lead to a 20% higher risk of BC;
The longer the CHC use, the higher the risk of BC;
The risk of BC remains for around five years after the cessation of CHC use;
The association of CHC and BC was significant after accounting for confounding factors (such as age at first birth, among others that can influence risk of BC);
The association of CHC and BC was particularly prominent in women who were aged younger than 35 years and nulliparous (had never given birth).
Women using CHC with P (gestodene, which is used in Denmark but not in the United States), showed a notable trend of ‘the longer the use, the higher the risk of BC’. In 1992, Jeng et al demonstrated that 19-nortestosterone derivatives, such as levonorgestrel (a type of P), are oestrogenic (they act through the oestrogen receptor [ER]) and facilitate human BC cell growth. In 1993, Catherino and et al demonstrated that levonorgestrel and gestodene facilitate human BC cell growth through the ER. The newer P, gestodene, was reported to carry twice the risk of blood clots compared with the older P levonorgestrel.
(* Source: https://www.pharmaceutical-journal.com/sign-in?rtn=opinion/correspondence/weighing-the-risks-and-benefits-of-contemporary-hormonal-contraception/20204208.article)
THE BOTTOM LINE: BIRTH CONTROL, IN FACT, DOES LEAD TO A HIGHER RISK OF BREAST CANCER!
If you are a woman between the ages of 15-49 years old, it is safer for you to practice natural family planning in place of chemical birth control pills. LEARN MORE!